Deutsche Bank AG Acquires New Holdings in DaVita Inc. $DVA

Deutsche Bank AG acquired a new position in shares of DaVita Inc. (NYSE:DVA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 208,362 shares of the company’s stock, valued at approximately $46,356,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. Invesco Ltd. grew its holdings in shares of DaVita by 2.0% during the third quarter. Invesco Ltd. now owns 1,679,248 shares of the company’s stock worth $223,122,000 after buying an additional 32,358 shares in the last quarter. Morgan Stanley grew its stake in DaVita by 5.1% in the 4th quarter. Morgan Stanley now owns 1,477,045 shares of the company’s stock valued at $167,807,000 after buying an additional 71,156 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in DaVita by 114.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company’s stock valued at $135,196,000 after purchasing an additional 636,191 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of DaVita by 5.2% in the first quarter. Dimensional Fund Advisors LP now owns 1,145,436 shares of the company’s stock valued at $176,037,000 after acquiring an additional 56,336 shares in the last quarter. Finally, LSV Asset Management raised its position in shares of DaVita by 1.1% in the fourth quarter. LSV Asset Management now owns 936,768 shares of the company’s stock valued at $106,426,000 after buying an additional 9,739 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of DVA stock opened at $174.21 on Friday. The company’s fifty day simple moving average is $214.96 and its two-hundred day simple moving average is $181.53. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $247.49. The stock has a market capitalization of $11.11 billion, a price-to-earnings ratio of 14.26, a PEG ratio of 0.58 and a beta of 0.88.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, beating the consensus estimate of $3.88 by $0.14. The company had revenue of $3.55 billion during the quarter, compared to analysts’ expectations of $3.50 billion. DaVita had a net margin of 6.05% and a negative return on equity of 217.63%. DaVita’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Equities research analysts anticipate that DaVita Inc. will post 14.57 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently issued reports on DVA shares. Barclays increased their price target on shares of DaVita from $218.00 to $224.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 5th. Weiss Ratings raised DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. UBS Group upped their price target on shares of DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $265.00 price objective on shares of DaVita in a report on Wednesday, August 5th. Finally, TD Cowen raised shares of DaVita from a “hold” rating to a “buy” rating and boosted their target price for the stock from $201.00 to $220.00 in a research report on Friday, August 7th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $221.75.

Insider Activity

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the transaction, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.90% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.